Cargando…

Autologous Stem Cell Therapy in Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Trials

OBJECTIVE: Critical limb ischemia (CLI) is the most dangerous stage of peripheral artery disease (PAD). Many basic researches and clinical treatment had been focused on stem cell transplantation for CLI. This systematic review was performed to review evidence for safety and efficacy of autologous st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Baocheng, Luo, Houlong, Zhang, Yusheng, Wang, Qinghui, Zhou, Chenhui, Xu, Daohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994285/ https://www.ncbi.nlm.nih.gov/pubmed/29977308 http://dx.doi.org/10.1155/2018/7528464

Ejemplares similares

Efficacy and Safety of the Injection of the Traditional Chinese Medicine Puerarin for the Treatment of Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis of 53 Randomized Controlled Trials
por: Xie, Baocheng, et al.
Publicado: (2018)

Stem Cell Therapy in Critical Limb Ischemia
por: Jeyaraman, Madhan, et al.
Publicado: (2023)

Autologous Stem Cells Transplantation for No-Option Angiitis-Induced Critical Limb Ischemia: Recurrence and New Lesion
por: Liu, Hao, et al.
Publicado: (2022)

Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia
por: Madaric, Juraj, et al.
Publicado: (2016)

Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia
por: Madaric, Juraj, et al.
Publicado: (2017)

Autologous Peripheral Blood Mononuclear Cells for Limb Salvage in Diabetic Foot Patients with No-Option Critical Limb Ischemia
por: Scatena, Alessia, et al.
Publicado: (2021)

Characterization of Mesenchymal Stem Cells of “No-Options” Patients with Critical Limb Ischemia Treated by Autologous Bone Marrow Mononuclear Cells
por: Altaner, Cestmir, et al.
Publicado: (2013)

Autologous angiogenic therapy with cultured mesenchymal stromal cells in platelet-rich plasma for critical limb ischemia
por: Fukuda, Shoji, et al.
Publicado: (2023)

Critical Limb Ischemia
por: Schanzer, Andres, et al.
Publicado: (2010)

Early Results of Clinical Application of Autologous Whole Bone Marrow Stem Cell Transplantation for Critical Limb Ischemia with Buerger’s Disease
por: Heo, Seon-Hee, et al.
Publicado: (2016)

Increasing the Therapeutic Potential of Stem Cell Therapies for Critical Limb Ischemia
por: Quiroz, Hallie J, et al.
Publicado: (2020)

Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia
por: Skóra, Jan, et al.
Publicado: (2014)

Kaempferol Ameliorates the Inhibitory Activity of Dexamethasone in the Osteogenesis of MC3T3-E1 Cells by JNK and p38-MAPK Pathways
por: Xie, Baocheng, et al.
Publicado: (2021)

A Molecular and Clinical Review of Stem Cell Therapy in Critical Limb Ischemia
por: Parikh, Punam P., et al.
Publicado: (2017)

Stem cell therapy in critical limb ischemia: Current scenario and future trends
por: Sharma, Arun, et al.
Publicado: (2019)

Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia
por: Shirbaghaee, Zeinab, et al.
Publicado: (2022)

Cell Therapy in Patients with Critical Limb Ischemia
por: Compagna, Rita, et al.
Publicado: (2015)

Deciphering the in vivo Dynamic Proteomics of Mesenchymal Stem Cells in Critical Limb Ischemia
por: Du, Yipeng, et al.
Publicado: (2021)

Autologous peripheral blood-derived stem cells transplantation for treatment of no-option angiitis-induced critical limb ischemia: 10-year management experience
por: Fang, Gang, et al.
Publicado: (2020)

Successful limb salvage by endovascular treatment for critical limb ischemia subsequent to acute limb ischemia
por: Nomura, Tetsuya, et al.
Publicado: (2019)

The Association of Cannabis Use Disorder with Acute Limb Ischemia and Critical Limb Ischemia
por: McGuinness, Brandon, et al.
Publicado: (2022)

Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia
por: Liew, Aaron, et al.
Publicado: (2012)

Bone marrow stem cell injection for the treatment of critical limb ischemia
por: Shindo, S
Publicado: (2007)

Difference in Serum Endostatin Levels in Diabetic Patients with Critical Limb Ischemia Treated by Autologous Cell Therapy or Percutaneous Transluminal Angioplasty
por: Nemcova, Andrea, et al.
Publicado: (2018)

The Diagnostic Classification of Critical Limb Ischemia
por: Azuma, Nobuyoshi
Publicado: (2018)

Relationship between cell number and clinical outcomes of autologous bone-marrow mononuclear cell implantation in critical limb ischemia
por: Yusoff, Farina Mohamad, et al.
Publicado: (2020)

Mesenchymal stem cells for critical limb ischemia: their function, mechanism, and therapeutic potential
por: Lozano Navarro, Laura V., et al.
Publicado: (2022)

Geniposide Alleviates Glucocorticoid-Induced Inhibition of Osteogenic Differentiation in MC3T3-E1 Cells by ERK Pathway
por: Xie, Baocheng, et al.
Publicado: (2019)

Graz Critical Limb Ischemia Score: A Risk Score for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease
por: Gary, Thomas, et al.
Publicado: (2015)

Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia
por: Pan, Tianyue, et al.
Publicado: (2019)

Review of the Long-term Effects of Autologous Bone-Marrow Mononuclear Cell Implantation on Clinical Outcomes in Patients with Critical Limb Ischemia
por: Yusoff, Farina Mohamad, et al.
Publicado: (2019)

Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-derived Mononuclear Cell Implantation in Patients with No-option Critical Limb Ischemia
por: Yanishi, Kenji, et al.
Publicado: (2020)

Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year results
por: Guo, Jianming, et al.
Publicado: (2018)

Our Treatment Strategy for Critical Limb Ischemia
por: Yamada, Tetsuo, et al.
Publicado: (2013)

The role of directional atherectomy in critical-limb ischemia
por: Krishnan, Prakash, et al.
Publicado: (2021)

Autologous immuno magnetically selected CD133+ stem cells in the treatment of no-option critical limb ischemia: clinical and contrast enhanced ultrasound assessed results in eight patients
por: Arici, Vittorio, et al.
Publicado: (2015)

Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia
por: Beegle, Julie R, et al.
Publicado: (2016)

Therapeutic Evidence of Human Mesenchymal Stem Cell Transplantation for Cerebral Palsy: A Meta-Analysis of Randomized Controlled Trials
por: Xie, Baocheng, et al.
Publicado: (2020)

Current Status of Cell-Based Therapy in Patients with Critical Limb Ischemia
por: Jaluvka, Frantisek, et al.
Publicado: (2020)

Mitochondrial Regulation of the Muscle Microenvironment in Critical Limb Ischemia
por: Ryan, Terence E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_adi4odkui4n39rhekahvgbodui